These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 15099972

  • 1. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
    Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R.
    Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
    [Abstract] [Full Text] [Related]

  • 2. Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients.
    Vicent S, Garayoa M, López-Picazo JM, Lozano MD, Toledo G, Thunnissen FB, Manzano RG, Montuenga LM.
    Clin Cancer Res; 2004 Jun 01; 10(11):3639-49. PubMed ID: 15173070
    [Abstract] [Full Text] [Related]

  • 3. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
    Givant-Horwitz V, Davidson B, Reich R.
    Cancer Res; 2004 May 15; 64(10):3572-9. PubMed ID: 15150114
    [Abstract] [Full Text] [Related]

  • 4. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis.
    Magi-Galluzzi C, Mishra R, Fiorentino M, Montironi R, Yao H, Capodieci P, Wishnow K, Kaplan I, Stork PJ, Loda M.
    Lab Invest; 1997 Jan 15; 76(1):37-51. PubMed ID: 9010448
    [Abstract] [Full Text] [Related]

  • 5. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R.
    Clin Cancer Res; 2001 Nov 15; 7(11):3457-64. PubMed ID: 11705863
    [Abstract] [Full Text] [Related]

  • 6. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation.
    Fürst R, Brueckl C, Kuebler WM, Zahler S, Krötz F, Görlach A, Vollmar AM, Kiemer AK.
    Circ Res; 2005 Jan 07; 96(1):43-53. PubMed ID: 15569826
    [Abstract] [Full Text] [Related]

  • 7. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.
    Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigioni W, Wang Y, Magi-Galluzzi C, Stork PJ.
    Am J Pathol; 1996 Nov 07; 149(5):1553-64. PubMed ID: 8909245
    [Abstract] [Full Text] [Related]

  • 8. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY, Liu Y, Wu GS.
    Cancer Res; 2006 May 01; 66(9):4888-94. PubMed ID: 16651445
    [Abstract] [Full Text] [Related]

  • 9. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
    Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, Lichtenegger W, Dietel M, Hauptmann S.
    Int J Cancer; 2002 Dec 10; 102(5):507-13. PubMed ID: 12432554
    [Abstract] [Full Text] [Related]

  • 10. Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells.
    Lornejad-Schäfer MR, Schäfer C, Graf D, Häussinger D, Schliess F.
    Biochem J; 2003 Apr 15; 371(Pt 2):609-19. PubMed ID: 12529177
    [Abstract] [Full Text] [Related]

  • 11. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW, Shi YY, Higgins LS, Orlowski RZ.
    Cancer Res; 2007 May 01; 67(9):4459-66. PubMed ID: 17483361
    [Abstract] [Full Text] [Related]

  • 12. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH, Kao YC, Chen BC, Chen CH, Chan P, Lee HM.
    Eur J Pharmacol; 2006 Jul 17; 541(3):138-46. PubMed ID: 16765938
    [Abstract] [Full Text] [Related]

  • 13. [Down regulation of mitogen activated protein kinase phosphatase-1 mediate acquired multidrug resistance in pancreatic adenocarcinoma cell line SW1990/Fu].
    Guo JC, Zhao YP, Liao Q, Chen G, Zhu Y.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):473-5. PubMed ID: 16772084
    [Abstract] [Full Text] [Related]

  • 14. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R.
    Gynecol Oncol; 2006 Dec 01; 103(3):831-40. PubMed ID: 16919315
    [Abstract] [Full Text] [Related]

  • 15. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R.
    Hum Pathol; 2009 May 01; 40(5):705-13. PubMed ID: 19157507
    [Abstract] [Full Text] [Related]

  • 16. Cellular defense against H2O2-induced apoptosis via MAP kinase-MKP-1 pathway.
    Xu Q, Konta T, Nakayama K, Furusu A, Moreno-Manzano V, Lucio-Cazana J, Ishikawa Y, Fine LG, Yao J, Kitamura M.
    Free Radic Biol Med; 2004 Apr 15; 36(8):985-93. PubMed ID: 15059639
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a variant of PAC-1 in large granular lymphocyte leukemia.
    Kothapalli R, Yoder SJ, Kusmartseva I, Loughran TP.
    Protein Expr Purif; 2003 Nov 15; 32(1):52-60. PubMed ID: 14680939
    [Abstract] [Full Text] [Related]

  • 18. The role of protein turnover in regulating MKP-1 levels in rat pinealocytes.
    Price DM, Terriff DL, Chik CL, Ho AK.
    Mol Cell Endocrinol; 2007 Jan 15; 263(1-2):134-41. PubMed ID: 17079074
    [Abstract] [Full Text] [Related]

  • 19. Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK.
    Small GW, Somasundaram S, Moore DT, Shi YY, Orlowski RZ.
    J Pharmacol Exp Ther; 2003 Dec 15; 307(3):861-9. PubMed ID: 14557375
    [Abstract] [Full Text] [Related]

  • 20. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
    Reddy ST, Nguyen JT, Grijalva V, Hough G, Hama S, Navab M, Fogelman AM.
    Arterioscler Thromb Vasc Biol; 2004 Sep 15; 24(9):1676-81. PubMed ID: 15242861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.